Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    September 2018
  1. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Text format     Abstract available


  2. SUZUKI M, Yokobori T, Gombodorj N, Yashiro M, et al
    High stromal transforming growth factor beta-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25217.
    PubMed     Text format     Abstract available


  3. GIULIANO K, Ejaz A, Reames BN, Choi W, et al
    Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.
    J Surg Oncol. 2018;118:486-492.
    PubMed     Text format     Abstract available


    July 2018
  4. KUKAR M, Gabriel E, Ben-David K, Hochwald SN, et al
    Laparoscopic proximal gastrectomy for gastric neoplasms.
    J Surg Oncol. 2018;118:95-100.
    PubMed     Text format     Abstract available


  5. COHEN NA, Strong VE, Janjigian YY
    Checkpoint blockade in esophagogastric cancer.
    J Surg Oncol. 2018;118:77-85.
    PubMed     Text format     Abstract available


    June 2018
  6. IKOMA N, Hofstetter WL, Estrella JS, Das P, et al
    The ypT category does not impact overall survival in node negative gastric cancer.
    J Surg Oncol. 2018 Jun 27. doi: 10.1002/jso.25081.
    PubMed     Text format     Abstract available


  7. YU JJ, Li JD, Yang T
    Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25070.
    PubMed     Text format    


  8. THIELS CA, Ikoma N, Fournier K, Das P, et al
    Repeat staging laparoscopy for gastric cancer after preoperative therapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25094.
    PubMed     Text format     Abstract available


  9. SZOR DJ, Dias AR, Pereira MA, Ramos MFKP, et al
    Reply to: "Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer".
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25069.
    PubMed     Text format    


  10. LANE WO, Nussbaum DP, Sun Z, Blazer DG, et al
    Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
    J Surg Oncol. 2018;117:1708-1715.
    PubMed     Text format     Abstract available


    May 2018
  11. KIM HS, Chon HJ, Kim H, Shin SJ, et al
    MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25097.
    PubMed     Text format     Abstract available


  12. WEN J, Bedford M, Begum R, Mitchell H, et al
    The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25057.
    PubMed     Text format     Abstract available


    March 2018
  13. PEREIRA MA, Ramos MFKP, Faraj SF, Dias AR, et al
    Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    J Surg Oncol. 2018 Mar 13. doi: 10.1002/jso.25022.
    PubMed     Text format     Abstract available


  14. MARTINS MR, Santos RLD, Jatahy KDN, Matta MCD, et al
    Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.25001.
    PubMed     Text format     Abstract available


  15. SZOR DJ, Roncon Dias A, Pereira MA, Ramos MFKP, et al
    Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.
    J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.25036.
    PubMed     Text format     Abstract available


  16. MIZRAK KAYA D, Nogueras-Gonzalez GM, Harada K, Amlashi FG, et al
    Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
    J Surg Oncol. 2018;117:678-684.
    PubMed     Text format     Abstract available


  17. GABRIEL E, Attwood K, Narayanan S, Brady M, et al
    Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?
    J Surg Oncol. 2018;117:659-670.
    PubMed     Text format     Abstract available


    January 2018
  18. NISHIZUKA SS, Tamura G, Nakatochi M, Fukushima N, et al
    Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24977.
    PubMed     Text format     Abstract available


    December 2017
  19. MURATA S, Yamamoto H, Shimizu T, Naitoh H, et al
    5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24906.
    PubMed     Text format     Abstract available


  20. IKOMA N, Cloyd J, Badgwell BD, Agnes A, et al
    Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24926.
    PubMed     Text format     Abstract available


  21. LI K, Cannon JGD, Jiang SY, Sambare TD, et al
    Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis.
    J Surg Oncol. 2017 Dec 4. doi: 10.1002/jso.24942.
    PubMed     Text format     Abstract available


  22. LEE JH, Tanaka E, Woo Y, Ali G, et al
    Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery.
    J Surg Oncol. 2017;116:894-897.
    PubMed     Text format     Abstract available


    November 2017
  23. LIU X, Li G, Long Z, Yin J, et al
    Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24917.
    PubMed     Text format     Abstract available


  24. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Text format     Abstract available


    August 2017
  25. DUAN W, Liu K, Fu X, Shen X, et al
    Semi-end-to-end esophagojejunostomy after laparoscopy-assisted total gastrectomy better reduces stricture and leakage than the conventional end-to-side procedure: A retrospective study.
    J Surg Oncol. 2017;116:177-183.
    PubMed     Text format     Abstract available


    July 2017
  26. MURATA S, Yamamoto H, Naitoh H, Yamaguchi T, et al
    Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24771.
    PubMed     Text format     Abstract available


  27. CHEN XD, Mao CC, Zhang WT, Lin J, et al
    A quantified risk-scoring system and rating model for postsurgical gastroparesis syndrome in gastric cancer patients.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24691.
    PubMed     Text format     Abstract available


    June 2017
  28. SON SY, Kong SH, Ahn HS, Park YS, et al
    The value of N staging with the positive lymph node ratio, and splenectomy, for remnant gastric cancer: A multicenter retrospective study.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24737.
    PubMed     Text format     Abstract available


  29. SAUNDERS JH, Bowman CR, Reece-Smith AM, Pang V, et al
    The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.
    J Surg Oncol. 2017;115:821-829.
    PubMed     Text format     Abstract available


    May 2017
  30. BUSWEILER LAD, Dikken JL, Henneman D, van Berge Henegouwen MI, et al
    The influence of a composite hospital volume on outcomes for gastric cancer surgery: A Dutch population-based study.
    J Surg Oncol. 2017 May 15. doi: 10.1002/jso.24562.
    PubMed     Text format     Abstract available


  31. LORENZON L, Cippitelli C, Avantifiori R, Uccini S, et al
    Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
    J Surg Oncol. 2017 May 5. doi: 10.1002/jso.24648.
    PubMed     Text format     Abstract available


    March 2017
  32. GIULIANO K, Nagarajan N, Canner J, Najafian A, et al
    Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ?
    J Surg Oncol. 2017;115:351-357.
    PubMed     Text format     Abstract available


    February 2017
  33. RUSSO A, Li P, Strong VE
    Differences in the multimodal treatment of gastric cancer: East versus west.
    J Surg Oncol. 2017 Feb 9. doi: 10.1002/jso.24517.
    PubMed     Text format     Abstract available


    December 2016
  34. RONA KA, Schwameis K, Zehetner J, Samakar K, et al
    Gastric cancer in the young: An advanced disease with poor prognostic features.
    J Surg Oncol. 2016 Dec 23. doi: 10.1002/jso.24533.
    PubMed     Text format     Abstract available


    November 2016
  35. FEINGOLD PL, Kwong ML, Davis JL, Rudloff U, et al
    Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.
    J Surg Oncol. 2016 Nov 23. doi: 10.1002/jso.24476.
    PubMed     Text format     Abstract available


  36. POLOM K, Marrelli D, Roviello G, Pascale V, et al
    Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability.
    J Surg Oncol. 2016 Nov 18. doi: 10.1002/jso.24513.
    PubMed     Text format     Abstract available


    October 2016
  37. IMAMURA T, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.
    J Surg Oncol. 2016;114:607-612.
    PubMed     Text format     Abstract available


  38. EL-HAGE A, Ruel C, Afif W, Wissanji H, et al
    Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases.
    J Surg Oncol. 2016;114:543-547.
    PubMed     Text format     Abstract available


  39. POSTLEWAIT LM, Baptiste GG, Ethun CG, Le N, et al
    A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
    J Surg Oncol. 2016;114:576-580.
    PubMed     Text format     Abstract available


    September 2016
  40. GERTLER R, Richter J, Stecher L, Nitsche U, et al
    What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    J Surg Oncol. 2016;114:428-33.
    PubMed     Text format     Abstract available


  41. RUSSELL MC
    Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.
    J Surg Oncol. 2016;114:296-303.
    PubMed     Text format     Abstract available


    August 2016
  42. BAPTISTE GG, Postlewait LM, Ethun CG, Le N, et al
    Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    J Surg Oncol. 2016;114:163-9.
    PubMed     Text format     Abstract available


    June 2016
  43. HERRERA-ALMARIO G, Patane M, Sarkaria I, Strong VE, et al
    Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy.
    J Surg Oncol. 2016;113:768-70.
    PubMed     Text format     Abstract available


    May 2016
  44. SERRANO OK, Love C, Goldman I, Huang K, et al
    The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
    J Surg Oncol. 2016;113:640-6.
    PubMed     Text format     Abstract available


    April 2016
  45. FUENTES E, Ahmad R, Hong TS, Clark JW, et al
    The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.
    J Surg Oncol. 2016;113:560-4.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: